Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

A new international clinical trial has shown that the oral form of semaglutide, a medication already known for managing type ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to ...

“Patients with heart valve issues should be particularly cautious about any oral care tools that could introduce bacteria into the bloodstream.” These tools pose similar risks to people with ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

People with a certain heart valve abnormality may be at an increased risk of developing severe heart rhythm disorders, also known as arrhythmias, according to a study on Tuesday. Researchers ...